We are monitoring the impact of COVID-19 on Latin America Regenerative Medicine Market Get in touch with us for detailed analysis Know More
Share on

Latin America Regenerative Medicine Market Research Report – Segmented By Product, Therapy, Application & Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) – Industry Analysis on Size, Share, Trends, COVID-19 Impact and Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 244
Pages: 145

Latin America Regenerative Medicine Market Size (2022 to 2027)

The size of the Latin America regenerative medicine market is estimated to worth USD 6.50 billion by 2027 and USD 2.15 billion in 2022, growing at a CAGR of 24.8% from 2022 to 2027.

Factors that are primarily fueling the growth of the Latin American regenerative medicine market, including increased consolidation among healthcare behemoths, an increase in the number of clinical trials for regenerative therapies, a favorable regulatory environment to expedite approvals and market entry, and increased awareness for stem cell therapeutics. One of the other primary factors expected to fuel market growth is the availability of a strong product pipeline in stem cell and gene therapy by various research institutions and leading industry competitors. Chronic diseases such as cardiovascular disease, cancer, diabetes, ulcers, and genetic disorders such as cystic fibrosis have grown considerably in frequency and prevalence worldwide. Diabetes and obesity can increase the incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, all of which require care and take a lot of time. The rising use of stem cell technologies, gene therapies, tissue engineering, and technical advancements in regenerative medicine is driving the Latin American regenerative medicine market forward.

The market expansion is further expected to be supported by a greater focus on stem cells and an increase in R&D efforts in emerging markets. Growing demands for organ transplantation in this region and the commercialization of regenerative medicine are some of the main factors expected to boost Latin America's regenerative medicine market trends throughout the forecast period. One of the major drivers of market expansion is increased skin substitutes, grafts, bone matrix, and other tissue-engineered regenerative medicine. Regenerated tracheas for transplant, 3D bioprinting, stem cell therapies for vision loss, and stem cell treatments for heart repair are recent advancements in regenerative medicine.

Government regulations, operational inefficiencies, and the high cost of regenerative medicine treatment are expected to slow the market's growth. Although there are differences between cell growth, tissue, and organs, developing sensors and quality control systems for regenerative medicine production presents significant challenges. For cell-based treatment batches, product loss or poor growth may delay testing or complete expansion.

Impact of COVID-19 on the Latin America Regenerative Medicine Market:

The abrupt change caused by COVID-19 Pandemic researcher has difficulty in conducting their regenerative medicine treatment. Transportation is also one of the obstacles hindering the growth of the market in this region. Increasing COVID-19 cases and demand to find a vaccine with various techniques is surging the growth of this market. Government policies and private funding are supporting researchers. Companies are highly investing in research and development to advance their regenerative medicine products to accelerate market growth in Mexico. In Brazil, an increasing number of regulatory approvals has made the market grow up significantly. The government takes initiatives and adopting the latest technology greatly influences the demand of the market.

This research report on the Latin American Regenerative Medicine Market has been segmented and sub-segmented into the following categories:

By Product:

  • Cell-Based Products                            
    • Autologous Cell-Based Products
    • Allogeneic Cell-Based Products  
  • Acellular Products           

By Therapy:

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Immunotherapy

By Application:

  • Orthopedic & Musculoskeletal Spine                           
  • Dermatology                          
  • Cardiovascular                       
  • Central Nervous System                   
  • Oncology                 
  • Diabetes                  
  • Other Applications         

Geographically, the Latin American market had accounted for a substantial share in the global market in 2020. During the forecast period, the Mexican regenerative medicine market is estimated to account significant share in the Latin American market. In Mexico, increasing incidences of chronic diseases such as Alzheimer’s disease, Parkinson’s disease, diabetes, heart disease, renal failure, osteoporosis, and spinal cord injuries which can be treated with regenerative medicine, are major factors for the market to grow. However, this is an expensive treatment where common people cannot afford is impeding the market growth.

The Brazilian regenerative medicine market is forecasted to register healthy CAGR from 2022 to 2027. The market's growth is largely driven by the introduction of the Cures Act for regenerative medicine by the FDA. Increased funding for regenerative medicine research, development of CAR-T cell therapies, and increasing demand for regenerative medicine to treat cancer, orthopedic disorders, and chronic diseases are solely propelling the market's growth.

KEY MARKET PLAYERS:

A few of the prominent companies dominating in the Latin America Regenerative Medicines Market are Vertex Pharmaceuticals Incorporated, Acelity L.P. Inc., Celgene Corporation, StemCells, Inc., Organogenesis Inc., NuVasive, Inc., Vericel Corporation (Genzyme), Japan Tissue Engineering Co., Ltd., Cytori Therapeutics Inc., Advantagene, Inc. and Mesoblast Ltd.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Introduction                                               

                5.2 Product                                        

                                5.2.1 Introduction                           

                                5.2.2 Cell-Based Products                            

                                                5.2.2.1 Autologous Cell-Based Products

                                                5.2.2.2 Allogeneic Cell-Based Products  

                                5.2.3 Acellular Products                

                5.3 Therapy                                       

                                5.3.1 Introduction                           

                                5.3.2 Cell Therapy                           

                                5.3.3 Gene Therapy                       

                                5.3.4 Tissue Engineering                               

                                5.3.5 Immunotherapy                   

                5.4 Application                                 

                                5.4.1 Introduction                           

                                5.4.2 Orthopedic & Musculoskeletal Spine                           

                                5.4.3 Dermatology                          

                                5.4.4 Cardiovascular                       

                                5.4.5 Central Nervous System                   

                                5.4.6 Oncology                 

                                5.4.7 Diabetes                  

                                5.4.8 Other Applications                               

6. Geographical Analysis                                                              

                                6.4.1 Introduction                           

                                6.4.2 Brazil                          

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Vertex Pharmaceuticals Incorporated (U.S.)                                

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Acelity L.P. Inc. (U.S.)                                             

                8.3 Celgene Corporation (U.S.)                                 

                8.4 StemCells, Inc. (U.S.)                                              

                8.5 Organogenesis Inc.  (U.S.)                                    

                8.6 NuVasive, Inc. (U.S.)                                              

                8.7 Vericel Corporation (Genzyme) (U.S.)                                            

                8.8 Cytori Therapeutics Inc. (U.S.)                                            

                8.9 Advantagene, Inc. (U.S.)                                      

                8.10 Mesoblast Ltd. (Australia)                                  

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  1. Latin America Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  2. Latin America Regenerative Medicines Market, By Product, From 2022 - 2027 (USD Billion)
  3. Latin America Cell-Based Products Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Acellular Products Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Regenerative Medicines Market, By Therapy, From 2022 - 2027 (USD Billion)
  6. Latin America Cell Therapy Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  7. Latin America Gene Therapy Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  8. Latin America Tissue Engineering Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  9. Latin America Immunotherapy Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  10. Latin America Regenerative Medicines Market, By Application, From 2022 - 2027 (USD Billion)
  11. Latin America Orthopedic & Musculoskeletal Spine Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  12. Latin America Dermatology Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  13. Latin America Cardiovascular Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  14. Latin America Central Nervous System Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  15. Latin America Oncology Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  16. Latin America Diabetes Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  17. Latin America Other Applications of Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  18. Brazil Regenerative Medicines Market, By Product, From 2022 - 2027 (USD Billion)
  19. Brazil Regenerative Medicines Market, By Therapy, From 2022 - 2027 (USD Billion)
  20. Brazil Regenerative Medicines Market, By Application, From 2022 - 2027 (USD Billion)
  21. Argentina Regenerative Medicines Market, By Product, From 2022 - 2027 (USD Billion)
  22. Argentina Regenerative Medicines Market, By Therapy, From 2022 - 2027 (USD Billion)
  23. Argentina Regenerative Medicines Market, By Application, From 2022 - 2027 (USD Billion)
  24. Mexico Regenerative Medicines Market, By Product, From 2022 - 2027 (USD Billion)
  25. Mexico Regenerative Medicines Market, By Therapy, From 2022 - 2027 (USD Billion)
  26. Mexico Regenerative Medicines Market, By Application, From 2022 - 2027 (USD Billion)
  27. Latin America Cell-Based Products Regenerative Medicines Market, By Type, From 2022 - 2027 (USD Billion)
  28. Latin America Autologous Cell-Based Products Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  29. Latin America Allogeneic Cell-Based Products Regenerative Medicines Market, By Region, From 2022 - 2027 (USD Billion)
  30. Brazil Cell-Based Products Regenerative Medicines Market, By Type, From 2022 - 2027 (USD Billion)
  31. Argentina Cell-Based Products Regenerative Medicines Market, By Type, From 2022 - 2027 (USD Billion)
  32. Mexico Cell-Based Products Regenerative Medicines Market, By Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample